APA (7th ed.) Citation

M, L., M, L., R, K., G, G., D, L., NA, T., & L, T. (2023). Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy. International journal of molecular sciences, 24(13), . https://doi.org/10.3390/ijms241310650

Chicago Style (17th ed.) Citation

M, Lutz, Levanti M, Karns R, Gourdon G, Lindquist D, Timchenko NA, and Timchenko L. "Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy." International Journal of Molecular Sciences 24, no. 13 (2023). https://doi.org/10.3390/ijms241310650.

MLA (9th ed.) Citation

M, Lutz, et al. "Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy." International Journal of Molecular Sciences, vol. 24, no. 13, 2023, https://doi.org/10.3390/ijms241310650.